[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Anti-tetanus Immunoglobulin Market - Global Outlook and Forecast 2021-2027

April 2021 | 103 pages | ID: A6D6663BDA64EN
Market Monitor Global

US$ 3,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report contains market size and forecasts of Anti-tetanus Immunoglobulin in global, including the following market information:

Global Anti-tetanus Immunoglobulin Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global Anti-tetanus Immunoglobulin Market Sales, 2016-2021, 2022-2027, (K Doses)

Global top five Anti-tetanus Immunoglobulin companies in 2020 (%)

The global Anti-tetanus Immunoglobulin market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Anti-tetanus Immunoglobulin manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Anti-tetanus Immunoglobulin Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Doses)

Global Anti-tetanus Immunoglobulin Market Segment Percentages, By Type, 2020 (%)
  • Injection
  • Freeze-dried Injection
Global Anti-tetanus Immunoglobulin Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Doses)

Global Anti-tetanus Immunoglobulin Market Segment Percentages, By Application, 2020 (%)
  • Adults
  • Children
Global Anti-tetanus Immunoglobulin Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (K Doses)

Global Anti-tetanus Immunoglobulin Market Segment Percentages, By Region and Country, 2020 (%)
  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Nordic Countries
    • Benelux
    • Rest of Europe
  • Asia
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Rest of Asia
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • Turkey
    • Israel
    • Saudi Arabia
    • UAE
    • Rest of Middle East & Africa
Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Anti-tetanus Immunoglobulin revenues in global market, 2016-2021 (Estimated), ($ millions)

Key companies Anti-tetanus Immunoglobulin revenues share in global market, 2020 (%)

Key companies Anti-tetanus Immunoglobulin sales in global market, 2016-2021 (Estimated), (K Doses)

Key companies Anti-tetanus Immunoglobulin sales share in global market, 2020 (%)

Further, the report presents profiles of competitors in the market, key players include:
  • SK Plasma
  • Baxalta
  • CSL
  • Octapharma
  • Grifols
  • LFB
  • Biotest
  • Kedrion
  • Hualan Biological Engineering
  • Sinopharm
  • Hualan Bio-Engineering
  • Nanyue Bio-Pharmaceutical
  • Tonglu Bio-Pharmaceutical
  • Sichuan Yuanda Shuyang Pharmaceutical
  • Wuhan Central Plain Ruide Bio-Products
  • Shandong Taibang Bio-Products
  • Guangdong Shuanglin Bio-Pharmaceutical
  • Chengdu Rongsheng Pharmaceutical
  • Shenzhen Weiguang Bio-Products
  • Guizhou Taibang Bio-Products
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Anti-tetanus Immunoglobulin Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Anti-tetanus Immunoglobulin Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL ANTI-TETANUS IMMUNOGLOBULIN OVERALL MARKET SIZE

2.1 Global Anti-tetanus Immunoglobulin Market Size: 2021 VS 2027
2.2 Global Anti-tetanus Immunoglobulin Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Anti-tetanus Immunoglobulin Sales (Consumption): 2016-2027

3 COMPANY LANDSCAPE

3.1 Top Anti-tetanus Immunoglobulin Players in Global Market
3.2 Top Global Anti-tetanus Immunoglobulin Companies Ranked by Revenue
3.3 Global Anti-tetanus Immunoglobulin Revenue by Companies
3.4 Global Anti-tetanus Immunoglobulin Sales by Companies
3.5 Global Anti-tetanus Immunoglobulin Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Anti-tetanus Immunoglobulin Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Anti-tetanus Immunoglobulin Product Type
3.8 Tier 1, Tier 2 and Tier 3 Anti-tetanus Immunoglobulin Players in Global Market
  3.8.1 List of Global Tier 1 Anti-tetanus Immunoglobulin Companies
  3.8.2 List of Global Tier 2 and Tier 3 Anti-tetanus Immunoglobulin Companies

4 SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Anti-tetanus Immunoglobulin Market Size Markets, 2021 & 2027
  4.1.2 Injection
  4.1.3 Freeze-dried Injection
4.2 By Type - Global Anti-tetanus Immunoglobulin Revenue & Forecasts
  4.2.1 By Type - Global Anti-tetanus Immunoglobulin Revenue, 2016-2021
  4.2.2 By Type - Global Anti-tetanus Immunoglobulin Revenue, 2022-2027
  4.2.3 By Type - Global Anti-tetanus Immunoglobulin Revenue Market Share, 2016-2027
4.3 By Type - Global Anti-tetanus Immunoglobulin Sales & Forecasts
  4.3.1 By Type - Global Anti-tetanus Immunoglobulin Sales, 2016-2021
  4.3.2 By Type - Global Anti-tetanus Immunoglobulin Sales, 2022-2027
  4.3.3 By Type - Global Anti-tetanus Immunoglobulin Sales Market Share, 2016-2027
4.4 By Type - Global Anti-tetanus Immunoglobulin Price (Manufacturers Selling Prices), 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Anti-tetanus Immunoglobulin Market Size, 2021 & 2027
  5.1.2 Adults
  5.1.3 Children
5.2 By Application - Global Anti-tetanus Immunoglobulin Revenue & Forecasts
  5.2.1 By Application - Global Anti-tetanus Immunoglobulin Revenue, 2016-2021
  5.2.2 By Application - Global Anti-tetanus Immunoglobulin Revenue, 2022-2027
  5.2.3 By Application - Global Anti-tetanus Immunoglobulin Revenue Market Share, 2016-2027
5.3 By Application - Global Anti-tetanus Immunoglobulin Sales & Forecasts
  5.3.1 By Application - Global Anti-tetanus Immunoglobulin Sales, 2016-2021
  5.3.2 By Application - Global Anti-tetanus Immunoglobulin Sales, 2022-2027
  5.3.3 By Application - Global Anti-tetanus Immunoglobulin Sales Market Share, 2016-2027
5.4 By Application - Global Anti-tetanus Immunoglobulin Price (Manufacturers Selling Prices), 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global Anti-tetanus Immunoglobulin Market Size, 2021 & 2027
6.2 By Region - Global Anti-tetanus Immunoglobulin Revenue & Forecasts
  6.2.1 By Region - Global Anti-tetanus Immunoglobulin Revenue, 2016-2021
  6.2.2 By Region - Global Anti-tetanus Immunoglobulin Revenue, 2022-2027
  6.2.3 By Region - Global Anti-tetanus Immunoglobulin Revenue Market Share, 2016-2027
6.3 By Region - Global Anti-tetanus Immunoglobulin Sales & Forecasts
  6.3.1 By Region - Global Anti-tetanus Immunoglobulin Sales, 2016-2021
  6.3.2 By Region - Global Anti-tetanus Immunoglobulin Sales, 2022-2027
  6.3.3 By Region - Global Anti-tetanus Immunoglobulin Sales Market Share, 2016-2027
6.4 North America
  6.4.1 By Country - North America Anti-tetanus Immunoglobulin Revenue, 2016-2027
  6.4.2 By Country - North America Anti-tetanus Immunoglobulin Sales, 2016-2027
  6.4.3 US Anti-tetanus Immunoglobulin Market Size, 2016-2027
  6.4.4 Canada Anti-tetanus Immunoglobulin Market Size, 2016-2027
  6.4.5 Mexico Anti-tetanus Immunoglobulin Market Size, 2016-2027
6.5 Europe
  6.5.1 By Country - Europe Anti-tetanus Immunoglobulin Revenue, 2016-2027
  6.5.2 By Country - Europe Anti-tetanus Immunoglobulin Sales, 2016-2027
  6.5.3 Germany Anti-tetanus Immunoglobulin Market Size, 2016-2027
  6.5.4 France Anti-tetanus Immunoglobulin Market Size, 2016-2027
  6.5.5 U.K. Anti-tetanus Immunoglobulin Market Size, 2016-2027
  6.5.6 Italy Anti-tetanus Immunoglobulin Market Size, 2016-2027
  6.5.7 Russia Anti-tetanus Immunoglobulin Market Size, 2016-2027
  6.5.8 Nordic Countries Anti-tetanus Immunoglobulin Market Size, 2016-2027
  6.5.9 Benelux Anti-tetanus Immunoglobulin Market Size, 2016-2027
6.6 Asia
  6.6.1 By Region - Asia Anti-tetanus Immunoglobulin Revenue, 2016-2027
  6.6.2 By Region - Asia Anti-tetanus Immunoglobulin Sales, 2016-2027
  6.6.3 China Anti-tetanus Immunoglobulin Market Size, 2016-2027
  6.6.4 Japan Anti-tetanus Immunoglobulin Market Size, 2016-2027
  6.6.5 South Korea Anti-tetanus Immunoglobulin Market Size, 2016-2027
  6.6.6 Southeast Asia Anti-tetanus Immunoglobulin Market Size, 2016-2027
  6.6.7 India Anti-tetanus Immunoglobulin Market Size, 2016-2027
6.7 South America
  6.7.1 By Country - South America Anti-tetanus Immunoglobulin Revenue, 2016-2027
  6.7.2 By Country - South America Anti-tetanus Immunoglobulin Sales, 2016-2027
  6.7.3 Brazil Anti-tetanus Immunoglobulin Market Size, 2016-2027
  6.7.4 Argentina Anti-tetanus Immunoglobulin Market Size, 2016-2027
6.8 Middle East & Africa
  6.8.1 By Country - Middle East & Africa Anti-tetanus Immunoglobulin Revenue, 2016-2027
  6.8.2 By Country - Middle East & Africa Anti-tetanus Immunoglobulin Sales, 2016-2027
  6.8.3 Turkey Anti-tetanus Immunoglobulin Market Size, 2016-2027
  6.8.4 Israel Anti-tetanus Immunoglobulin Market Size, 2016-2027
  6.8.5 Saudi Arabia Anti-tetanus Immunoglobulin Market Size, 2016-2027
  6.8.6 UAE Anti-tetanus Immunoglobulin Market Size, 2016-2027

7 MANUFACTURERS & BRANDS PROFILES

7.1 SK Plasma
  7.1.1 SK Plasma Corporate Summary
  7.1.2 SK Plasma Business Overview
  7.1.3 SK Plasma Anti-tetanus Immunoglobulin Major Product Offerings
  7.1.4 SK Plasma Anti-tetanus Immunoglobulin Sales and Revenue in Global (2016-2021)
  7.1.5 SK Plasma Key News
7.2 Baxalta
  7.2.1 Baxalta Corporate Summary
  7.2.2 Baxalta Business Overview
  7.2.3 Baxalta Anti-tetanus Immunoglobulin Major Product Offerings
  7.2.4 Baxalta Anti-tetanus Immunoglobulin Sales and Revenue in Global (2016-2021)
  7.2.5 Baxalta Key News
7.3 CSL
  7.3.1 CSL Corporate Summary
  7.3.2 CSL Business Overview
  7.3.3 CSL Anti-tetanus Immunoglobulin Major Product Offerings
  7.3.4 CSL Anti-tetanus Immunoglobulin Sales and Revenue in Global (2016-2021)
  7.3.5 CSL Key News
7.4 Octapharma
  7.4.1 Octapharma Corporate Summary
  7.4.2 Octapharma Business Overview
  7.4.3 Octapharma Anti-tetanus Immunoglobulin Major Product Offerings
  7.4.4 Octapharma Anti-tetanus Immunoglobulin Sales and Revenue in Global (2016-2021)
  7.4.5 Octapharma Key News
7.5 Grifols
  7.5.1 Grifols Corporate Summary
  7.5.2 Grifols Business Overview
  7.5.3 Grifols Anti-tetanus Immunoglobulin Major Product Offerings
  7.5.4 Grifols Anti-tetanus Immunoglobulin Sales and Revenue in Global (2016-2021)
  7.5.5 Grifols Key News
7.6 LFB
  7.6.1 LFB Corporate Summary
  7.6.2 LFB Business Overview
  7.6.3 LFB Anti-tetanus Immunoglobulin Major Product Offerings
  7.6.4 LFB Anti-tetanus Immunoglobulin Sales and Revenue in Global (2016-2021)
  7.6.5 LFB Key News
7.7 Biotest
  7.7.1 Biotest Corporate Summary
  7.7.2 Biotest Business Overview
  7.7.3 Biotest Anti-tetanus Immunoglobulin Major Product Offerings
  7.4.4 Biotest Anti-tetanus Immunoglobulin Sales and Revenue in Global (2016-2021)
  7.7.5 Biotest Key News
7.8 Kedrion
  7.8.1 Kedrion Corporate Summary
  7.8.2 Kedrion Business Overview
  7.8.3 Kedrion Anti-tetanus Immunoglobulin Major Product Offerings
  7.8.4 Kedrion Anti-tetanus Immunoglobulin Sales and Revenue in Global (2016-2021)
  7.8.5 Kedrion Key News
7.9 Hualan Biological Engineering
  7.9.1 Hualan Biological Engineering Corporate Summary
  7.9.2 Hualan Biological Engineering Business Overview
  7.9.3 Hualan Biological Engineering Anti-tetanus Immunoglobulin Major Product Offerings
  7.9.4 Hualan Biological Engineering Anti-tetanus Immunoglobulin Sales and Revenue in Global (2016-2021)
  7.9.5 Hualan Biological Engineering Key News
7.10 Sinopharm
  7.10.1 Sinopharm Corporate Summary
  7.10.2 Sinopharm Business Overview
  7.10.3 Sinopharm Anti-tetanus Immunoglobulin Major Product Offerings
  7.10.4 Sinopharm Anti-tetanus Immunoglobulin Sales and Revenue in Global (2016-2021)
  7.10.5 Sinopharm Key News
7.11 Hualan Bio-Engineering
  7.11.1 Hualan Bio-Engineering Corporate Summary
  7.11.2 Hualan Bio-Engineering Anti-tetanus Immunoglobulin Business Overview
  7.11.3 Hualan Bio-Engineering Anti-tetanus Immunoglobulin Major Product Offerings
  7.11.4 Hualan Bio-Engineering Anti-tetanus Immunoglobulin Sales and Revenue in Global (2016-2021)
  7.11.5 Hualan Bio-Engineering Key News
7.12 Nanyue Bio-Pharmaceutical
  7.12.1 Nanyue Bio-Pharmaceutical Corporate Summary
  7.12.2 Nanyue Bio-Pharmaceutical Anti-tetanus Immunoglobulin Business Overview
  7.12.3 Nanyue Bio-Pharmaceutical Anti-tetanus Immunoglobulin Major Product Offerings
  7.12.4 Nanyue Bio-Pharmaceutical Anti-tetanus Immunoglobulin Sales and Revenue in Global (2016-2021)
  7.12.5 Nanyue Bio-Pharmaceutical Key News
7.13 Tonglu Bio-Pharmaceutical
  7.13.1 Tonglu Bio-Pharmaceutical Corporate Summary
  7.13.2 Tonglu Bio-Pharmaceutical Anti-tetanus Immunoglobulin Business Overview
  7.13.3 Tonglu Bio-Pharmaceutical Anti-tetanus Immunoglobulin Major Product Offerings
  7.13.4 Tonglu Bio-Pharmaceutical Anti-tetanus Immunoglobulin Sales and Revenue in Global (2016-2021)
  7.13.5 Tonglu Bio-Pharmaceutical Key News
7.14 Sichuan Yuanda Shuyang Pharmaceutical
  7.14.1 Sichuan Yuanda Shuyang Pharmaceutical Corporate Summary
  7.14.2 Sichuan Yuanda Shuyang Pharmaceutical Business Overview
  7.14.3 Sichuan Yuanda Shuyang Pharmaceutical Anti-tetanus Immunoglobulin Major Product Offerings
  7.14.4 Sichuan Yuanda Shuyang Pharmaceutical Anti-tetanus Immunoglobulin Sales and Revenue in Global (2016-2021)
  7.14.5 Sichuan Yuanda Shuyang Pharmaceutical Key News
7.15 Wuhan Central Plain Ruide Bio-Products
  7.15.1 Wuhan Central Plain Ruide Bio-Products Corporate Summary
  7.15.2 Wuhan Central Plain Ruide Bio-Products Business Overview
  7.15.3 Wuhan Central Plain Ruide Bio-Products Anti-tetanus Immunoglobulin Major Product Offerings
  7.15.4 Wuhan Central Plain Ruide Bio-Products Anti-tetanus Immunoglobulin Sales and Revenue in Global (2016-2021)
  7.15.5 Wuhan Central Plain Ruide Bio-Products Key News
7.16 Shandong Taibang Bio-Products
  7.16.1 Shandong Taibang Bio-Products Corporate Summary
  7.16.2 Shandong Taibang Bio-Products Business Overview
  7.16.3 Shandong Taibang Bio-Products Anti-tetanus Immunoglobulin Major Product Offerings
  7.16.4 Shandong Taibang Bio-Products Anti-tetanus Immunoglobulin Sales and Revenue in Global (2016-2021)
  7.16.5 Shandong Taibang Bio-Products Key News
7.17 Guangdong Shuanglin Bio-Pharmaceutical
  7.17.1 Guangdong Shuanglin Bio-Pharmaceutical Corporate Summary
  7.17.2 Guangdong Shuanglin Bio-Pharmaceutical Business Overview
  7.17.3 Guangdong Shuanglin Bio-Pharmaceutical Anti-tetanus Immunoglobulin Major Product Offerings
  7.17.4 Guangdong Shuanglin Bio-Pharmaceutical Anti-tetanus Immunoglobulin Sales and Revenue in Global (2016-2021)
  7.17.5 Guangdong Shuanglin Bio-Pharmaceutical Key News
7.18 Chengdu Rongsheng Pharmaceutical
  7.18.1 Chengdu Rongsheng Pharmaceutical Corporate Summary
  7.18.2 Chengdu Rongsheng Pharmaceutical Business Overview
  7.18.3 Chengdu Rongsheng Pharmaceutical Anti-tetanus Immunoglobulin Major Product Offerings
  7.18.4 Chengdu Rongsheng Pharmaceutical Anti-tetanus Immunoglobulin Sales and Revenue in Global (2016-2021)
  7.18.5 Chengdu Rongsheng Pharmaceutical Key News
7.19 Shenzhen Weiguang Bio-Products
  7.19.1 Shenzhen Weiguang Bio-Products Corporate Summary
  7.19.2 Shenzhen Weiguang Bio-Products Business Overview
  7.19.3 Shenzhen Weiguang Bio-Products Anti-tetanus Immunoglobulin Major Product Offerings
  7.19.4 Shenzhen Weiguang Bio-Products Anti-tetanus Immunoglobulin Sales and Revenue in Global (2016-2021)
  7.19.5 Shenzhen Weiguang Bio-Products Key News
7.20 Guizhou Taibang Bio-Products
  7.20.1 Guizhou Taibang Bio-Products Corporate Summary
  7.20.2 Guizhou Taibang Bio-Products Business Overview
  7.20.3 Guizhou Taibang Bio-Products Anti-tetanus Immunoglobulin Major Product Offerings
  7.20.4 Guizhou Taibang Bio-Products Anti-tetanus Immunoglobulin Sales and Revenue in Global (2016-2021)
  7.20.5 Guizhou Taibang Bio-Products Key News

8 GLOBAL ANTI-TETANUS IMMUNOGLOBULIN PRODUCTION CAPACITY, ANALYSIS

8.1 Global Anti-tetanus Immunoglobulin Production Capacity, 2016-2027
8.2 Anti-tetanus Immunoglobulin Production Capacity of Key Manufacturers in Global Market
8.3 Global Anti-tetanus Immunoglobulin Production by Region

9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS

9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints

10 ANTI-TETANUS IMMUNOGLOBULIN SUPPLY CHAIN ANALYSIS

10.1 Anti-tetanus Immunoglobulin Industry Value Chain
10.2 Anti-tetanus Immunoglobulin Upstream Market
10.3 Anti-tetanus Immunoglobulin Downstream and Clients
10.4 Marketing Channels Analysis
  10.4.1 Marketing Channels
  10.4.2 Anti-tetanus Immunoglobulin Distributors and Sales Agents in Global

11 CONCLUSION

12 APPENDIX

12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES

Table 1. Key Players of Anti-tetanus Immunoglobulin in Global Market
Table 2. Top Anti-tetanus Immunoglobulin Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Anti-tetanus Immunoglobulin Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Anti-tetanus Immunoglobulin Revenue Share by Companies, 2016-2021
Table 5. Global Anti-tetanus Immunoglobulin Sales by Companies, (K Doses), 2016-2021
Table 6. Global Anti-tetanus Immunoglobulin Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Anti-tetanus Immunoglobulin Price (2016-2021) & (US$/Dose)
Table 8. Global Manufacturers Anti-tetanus Immunoglobulin Product Type
Table 9. List of Global Tier 1 Anti-tetanus Immunoglobulin Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Anti-tetanus Immunoglobulin Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Anti-tetanus Immunoglobulin Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Global Anti-tetanus Immunoglobulin Revenue (US$, Mn), 2016-2021
Table 13. By Type - Global Anti-tetanus Immunoglobulin Revenue (US$, Mn), 2022-2027
Table 14. By Type - Global Anti-tetanus Immunoglobulin Sales (K Doses), 2016-2021
Table 15. By Type - Global Anti-tetanus Immunoglobulin Sales (K Doses), 2022-2027
Table 16. By Application – Global Anti-tetanus Immunoglobulin Revenue, (US$, Mn), 2021 VS 2027
Table 17. By Application - Global Anti-tetanus Immunoglobulin Revenue (US$, Mn), 2016-2021
Table 18. By Application - Global Anti-tetanus Immunoglobulin Revenue (US$, Mn), 2022-2027
Table 19. By Application - Global Anti-tetanus Immunoglobulin Sales (K Doses), 2016-2021
Table 20. By Application - Global Anti-tetanus Immunoglobulin Sales (K Doses), 2022-2027
Table 21. By Region – Global Anti-tetanus Immunoglobulin Revenue, (US$, Mn), 2021 VS 2027
Table 22. By Region - Global Anti-tetanus Immunoglobulin Revenue (US$, Mn), 2016-2021
Table 23. By Region - Global Anti-tetanus Immunoglobulin Revenue (US$, Mn), 2022-2027
Table 24. By Region - Global Anti-tetanus Immunoglobulin Sales (K Doses), 2016-2021
Table 25. By Region - Global Anti-tetanus Immunoglobulin Sales (K Doses), 2022-2027
Table 26. By Country - North America Anti-tetanus Immunoglobulin Revenue, (US$, Mn), 2016-2021
Table 27. By Country - North America Anti-tetanus Immunoglobulin Revenue, (US$, Mn), 2022-2027
Table 28. By Country - North America Anti-tetanus Immunoglobulin Sales, (K Doses), 2016-2021
Table 29. By Country - North America Anti-tetanus Immunoglobulin Sales, (K Doses), 2022-2027
Table 30. By Country - Europe Anti-tetanus Immunoglobulin Revenue, (US$, Mn), 2016-2021
Table 31. By Country - Europe Anti-tetanus Immunoglobulin Revenue, (US$, Mn), 2022-2027
Table 32. By Country - Europe Anti-tetanus Immunoglobulin Sales, (K Doses), 2016-2021
Table 33. By Country - Europe Anti-tetanus Immunoglobulin Sales, (K Doses), 2022-2027
Table 34. By Region - Asia Anti-tetanus Immunoglobulin Revenue, (US$, Mn), 2016-2021
Table 35. By Region - Asia Anti-tetanus Immunoglobulin Revenue, (US$, Mn), 2022-2027
Table 36. By Region - Asia Anti-tetanus Immunoglobulin Sales, (K Doses), 2016-2021
Table 37. By Region - Asia Anti-tetanus Immunoglobulin Sales, (K Doses), 2022-2027
Table 38. By Country - South America Anti-tetanus Immunoglobulin Revenue, (US$, Mn), 2016-2021
Table 39. By Country - South America Anti-tetanus Immunoglobulin Revenue, (US$, Mn), 2022-2027
Table 40. By Country - South America Anti-tetanus Immunoglobulin Sales, (K Doses), 2016-2021
Table 41. By Country - South America Anti-tetanus Immunoglobulin Sales, (K Doses), 2022-2027
Table 42. By Country - Middle East & Africa Anti-tetanus Immunoglobulin Revenue, (US$, Mn), 2016-2021
Table 43. By Country - Middle East & Africa Anti-tetanus Immunoglobulin Revenue, (US$, Mn), 2022-2027
Table 44. By Country - Middle East & Africa Anti-tetanus Immunoglobulin Sales, (K Doses), 2016-2021
Table 45. By Country - Middle East & Africa Anti-tetanus Immunoglobulin Sales, (K Doses), 2022-2027
Table 46. SK Plasma Corporate Summary
Table 47. SK Plasma Anti-tetanus Immunoglobulin Product Offerings
Table 48. SK Plasma Anti-tetanus Immunoglobulin Sales (K Doses), Revenue (US$, Mn) and Average Price (US$/Dose) (2016-2021)
Table 49. Baxalta Corporate Summary
Table 50. Baxalta Anti-tetanus Immunoglobulin Product Offerings
Table 51. Baxalta Anti-tetanus Immunoglobulin Sales (K Doses), Revenue (US$, Mn) and Average Price (US$/Dose) (2016-2021)
Table 52. CSL Corporate Summary
Table 53. CSL Anti-tetanus Immunoglobulin Product Offerings
Table 54. CSL Anti-tetanus Immunoglobulin Sales (K Doses), Revenue (US$, Mn) and Average Price (US$/Dose) (2016-2021)
Table 55. Octapharma Corporate Summary
Table 56. Octapharma Anti-tetanus Immunoglobulin Product Offerings
Table 57. Octapharma Anti-tetanus Immunoglobulin Sales (K Doses), Revenue (US$, Mn) and Average Price (US$/Dose) (2016-2021)
Table 58. Grifols Corporate Summary
Table 59. Grifols Anti-tetanus Immunoglobulin Product Offerings
Table 60. Grifols Anti-tetanus Immunoglobulin Sales (K Doses), Revenue (US$, Mn) and Average Price (US$/Dose) (2016-2021)
Table 61. LFB Corporate Summary
Table 62. LFB Anti-tetanus Immunoglobulin Product Offerings
Table 63. LFB Anti-tetanus Immunoglobulin Sales (K Doses), Revenue (US$, Mn) and Average Price (US$/Dose) (2016-2021)
Table 64. Biotest Corporate Summary
Table 65. Biotest Anti-tetanus Immunoglobulin Product Offerings
Table 66. Biotest Anti-tetanus Immunoglobulin Sales (K Doses), Revenue (US$, Mn) and Average Price (US$/Dose) (2016-2021)
Table 67. Kedrion Corporate Summary
Table 68. Kedrion Anti-tetanus Immunoglobulin Product Offerings
Table 69. Kedrion Anti-tetanus Immunoglobulin Sales (K Doses), Revenue (US$, Mn) and Average Price (US$/Dose) (2016-2021)
Table 70. Hualan Biological Engineering Corporate Summary
Table 71. Hualan Biological Engineering Anti-tetanus Immunoglobulin Product Offerings
Table 72. Hualan Biological Engineering Anti-tetanus Immunoglobulin Sales (K Doses), Revenue (US$, Mn) and Average Price (US$/Dose) (2016-2021)
Table 73. Sinopharm Corporate Summary
Table 74. Sinopharm Anti-tetanus Immunoglobulin Product Offerings
Table 75. Sinopharm Anti-tetanus Immunoglobulin Sales (K Doses), Revenue (US$, Mn) and Average Price (US$/Dose) (2016-2021)
Table 76. Hualan Bio-Engineering Corporate Summary
Table 77. Hualan Bio-Engineering Anti-tetanus Immunoglobulin Product Offerings
Table 78. Hualan Bio-Engineering Anti-tetanus Immunoglobulin Sales (K Doses), Revenue (US$, Mn) and Average Price (US$/Dose) (2016-2021)
Table 79. Nanyue Bio-Pharmaceutical Corporate Summary
Table 80. Nanyue Bio-Pharmaceutical Anti-tetanus Immunoglobulin Product Offerings
Table 81. Nanyue Bio-Pharmaceutical Anti-tetanus Immunoglobulin Sales (K Doses), Revenue (US$, Mn) and Average Price (US$/Dose) (2016-2021)
Table 82. Tonglu Bio-Pharmaceutical Corporate Summary
Table 83. Tonglu Bio-Pharmaceutical Anti-tetanus Immunoglobulin Product Offerings
Table 84. Tonglu Bio-Pharmaceutical Anti-tetanus Immunoglobulin Sales (K Doses), Revenue (US$, Mn) and Average Price (US$/Dose) (2016-2021)
Table 85. Sichuan Yuanda Shuyang Pharmaceutical Corporate Summary
Table 86. Sichuan Yuanda Shuyang Pharmaceutical Anti-tetanus Immunoglobulin Product Offerings
Table 87. Sichuan Yuanda Shuyang Pharmaceutical Anti-tetanus Immunoglobulin Sales (K Doses), Revenue (US$, Mn) and Average Price (US$/Dose) (2016-2021)
Table 88. Wuhan Central Plain Ruide Bio-Products Corporate Summary
Table 89. Wuhan Central Plain Ruide Bio-Products Anti-tetanus Immunoglobulin Product Offerings
Table 90. Wuhan Central Plain Ruide Bio-Products Anti-tetanus Immunoglobulin Sales (K Doses), Revenue (US$, Mn) and Average Price (US$/Dose) (2016-2021)
Table 91. Shandong Taibang Bio-Products Corporate Summary
Table 92. Shandong Taibang Bio-Products Anti-tetanus Immunoglobulin Product Offerings
Table 93. Shandong Taibang Bio-Products Anti-tetanus Immunoglobulin Sales (K Doses), Revenue (US$, Mn) and Average Price (US$/Dose) (2016-2021)
Table 94. Guangdong Shuanglin Bio-Pharmaceutical Corporate Summary
Table 95. Guangdong Shuanglin Bio-Pharmaceutical Anti-tetanus Immunoglobulin Product Offerings
Table 96. Guangdong Shuanglin Bio-Pharmaceutical Anti-tetanus Immunoglobulin Sales (K Doses), Revenue (US$, Mn) and Average Price (US$/Dose) (2016-2021)
Table 97. Chengdu Rongsheng Pharmaceutical Corporate Summary
Table 98. Chengdu Rongsheng Pharmaceutical Anti-tetanus Immunoglobulin Product Offerings
Table 99. Chengdu Rongsheng Pharmaceutical Anti-tetanus Immunoglobulin Sales (K Doses), Revenue (US$, Mn) and Average Price (US$/Dose) (2016-2021)
Table 100. Shenzhen Weiguang Bio-Products Corporate Summary
Table 101. Shenzhen Weiguang Bio-Products Anti-tetanus Immunoglobulin Product Offerings
Table 102. Shenzhen Weiguang Bio-Products Anti-tetanus Immunoglobulin Sales (K Doses), Revenue (US$, Mn) and Average Price (US$/Dose) (2016-2021)
Table 103. Guizhou Taibang Bio-Products Corporate Summary
Table 104. Guizhou Taibang Bio-Products Anti-tetanus Immunoglobulin Product Offerings
Table 105. Guizhou Taibang Bio-Products Anti-tetanus Immunoglobulin Sales (K Doses), Revenue (US$, Mn) and Average Price (US$/Dose) (2016-2021)
Table 106. Anti-tetanus Immunoglobulin Production Capacity (K Doses) of Key Manufacturers in Global Market, 2019-2021 (K Doses)
Table 107. Global Anti-tetanus Immunoglobulin Capacity Market Share of Key Manufacturers, 2019-2021
Table 108. Global Anti-tetanus Immunoglobulin Production by Region, 2016-2021 (K Doses)
Table 109. Global Anti-tetanus Immunoglobulin Production by Region, 2022-2027 (K Doses)
Table 110. Anti-tetanus Immunoglobulin Market Opportunities & Trends in Global Market
Table 111. Anti-tetanus Immunoglobulin Market Drivers in Global Market
Table 112. Anti-tetanus Immunoglobulin Market Restraints in Global Market
Table 113. Anti-tetanus Immunoglobulin Raw Materials
Table 114. Anti-tetanus Immunoglobulin Raw Materials Suppliers in Global Market
Table 115. Typical Anti-tetanus Immunoglobulin Downstream
Table 116. Anti-tetanus Immunoglobulin Downstream Clients in Global Market
Table 117. Anti-tetanus Immunoglobulin Distributors and Sales Agents in Global Market

LIST OF FIGURES

Figure 1. Anti-tetanus Immunoglobulin Segment by Type
Figure 2. Anti-tetanus Immunoglobulin Segment by Application
Figure 3. Global Anti-tetanus Immunoglobulin Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Anti-tetanus Immunoglobulin Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Anti-tetanus Immunoglobulin Revenue, 2016-2027 (US$, Mn)
Figure 7. Anti-tetanus Immunoglobulin Sales in Global Market: 2016-2027 (K Doses)
Figure 8. The Top 3 and 5 Players Market Share by Anti-tetanus Immunoglobulin Revenue in 2020
Figure 9. By Type - Global Anti-tetanus Immunoglobulin Sales Market Share, 2016-2027
Figure 10. By Type - Global Anti-tetanus Immunoglobulin Revenue Market Share, 2016-2027
Figure 11. By Type - Global Anti-tetanus Immunoglobulin Price (US$/Dose), 2016-2027
Figure 12. By Application - Global Anti-tetanus Immunoglobulin Sales Market Share, 2016-2027
Figure 13. By Application - Global Anti-tetanus Immunoglobulin Revenue Market Share, 2016-2027
Figure 14. By Application - Global Anti-tetanus Immunoglobulin Price (US$/Dose), 2016-2027
Figure 15. By Region - Global Anti-tetanus Immunoglobulin Sales Market Share, 2016-2027
Figure 16. By Region - Global Anti-tetanus Immunoglobulin Revenue Market Share, 2016-2027
Figure 17. By Country - North America Anti-tetanus Immunoglobulin Revenue Market Share, 2016-2027
Figure 18. By Country - North America Anti-tetanus Immunoglobulin Sales Market Share, 2016-2027
Figure 19. US Anti-tetanus Immunoglobulin Revenue, (US$, Mn), 2016-2027
Figure 20. Canada Anti-tetanus Immunoglobulin Revenue, (US$, Mn), 2016-2027
Figure 21. Mexico Anti-tetanus Immunoglobulin Revenue, (US$, Mn), 2016-2027
Figure 22. By Country - Europe Anti-tetanus Immunoglobulin Revenue Market Share, 2016-2027
Figure 23. By Country - Europe Anti-tetanus Immunoglobulin Sales Market Share, 2016-2027
Figure 24. Germany Anti-tetanus Immunoglobulin Revenue, (US$, Mn), 2016-2027
Figure 25. France Anti-tetanus Immunoglobulin Revenue, (US$, Mn), 2016-2027
Figure 26. U.K. Anti-tetanus Immunoglobulin Revenue, (US$, Mn), 2016-2027
Figure 27. Italy Anti-tetanus Immunoglobulin Revenue, (US$, Mn), 2016-2027
Figure 28. Russia Anti-tetanus Immunoglobulin Revenue, (US$, Mn), 2016-2027
Figure 29. Nordic Countries Anti-tetanus Immunoglobulin Revenue, (US$, Mn), 2016-2027
Figure 30. Benelux Anti-tetanus Immunoglobulin Revenue, (US$, Mn), 2016-2027
Figure 31. By Region - Asia Anti-tetanus Immunoglobulin Revenue Market Share, 2016-2027
Figure 32. By Region - Asia Anti-tetanus Immunoglobulin Sales Market Share, 2016-2027
Figure 33. China Anti-tetanus Immunoglobulin Revenue, (US$, Mn), 2016-2027
Figure 34. Japan Anti-tetanus Immunoglobulin Revenue, (US$, Mn), 2016-2027
Figure 35. South Korea Anti-tetanus Immunoglobulin Revenue, (US$, Mn), 2016-2027
Figure 36. Southeast Asia Anti-tetanus Immunoglobulin Revenue, (US$, Mn), 2016-2027
Figure 37. India Anti-tetanus Immunoglobulin Revenue, (US$, Mn), 2016-2027
Figure 38. By Country - South America Anti-tetanus Immunoglobulin Revenue Market Share, 2016-2027
Figure 39. By Country - South America Anti-tetanus Immunoglobulin Sales Market Share, 2016-2027
Figure 40. Brazil Anti-tetanus Immunoglobulin Revenue, (US$, Mn), 2016-2027
Figure 41. Argentina Anti-tetanus Immunoglobulin Revenue, (US$, Mn), 2016-2027
Figure 42. By Country - Middle East & Africa Anti-tetanus Immunoglobulin Revenue Market Share, 2016-2027
Figure 43. By Country - Middle East & Africa Anti-tetanus Immunoglobulin Sales Market Share, 2016-2027
Figure 44. Turkey Anti-tetanus Immunoglobulin Revenue, (US$, Mn), 2016-2027
Figure 45. Israel Anti-tetanus Immunoglobulin Revenue, (US$, Mn), 2016-2027
Figure 46. Saudi Arabia Anti-tetanus Immunoglobulin Revenue, (US$, Mn), 2016-2027
Figure 47. UAE Anti-tetanus Immunoglobulin Revenue, (US$, Mn), 2016-2027
Figure 48. Global Anti-tetanus Immunoglobulin Production Capacity (K Doses), 2016-2027
Figure 49. The Percentage of Production Anti-tetanus Immunoglobulin by Region, 2020 VS 2027
Figure 50. Anti-tetanus Immunoglobulin Industry Value Chain
Figure 51. Marketing Channels


More Publications